United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
475.85
+2.65 (0.56%)
Feb 11, 2026, 4:00 PM EST - Market closed
United Therapeutics Employees
United Therapeutics had 1,305 employees as of December 31, 2024. The number of employees increased by 137 or 11.73% compared to the previous year.
Employees
1,305
Change (1Y)
137
Growth (1Y)
11.73%
Revenue / Employee
$2,397,241
Profits / Employee
$974,483
Market Cap
20.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,305 | 137 | 11.73% |
| Dec 31, 2023 | 1,168 | 183 | 18.58% |
| Dec 31, 2022 | 985 | 20 | 2.07% |
| Dec 31, 2021 | 965 | 15 | 1.58% |
| Dec 31, 2020 | 950 | 30 | 3.26% |
| Dec 31, 2019 | 920 | 60 | 6.98% |
| Dec 31, 2018 | 860 | 60 | 7.50% |
| Dec 31, 2017 | 800 | 50 | 6.67% |
| Dec 31, 2016 | 750 | 0 | - |
| Dec 31, 2015 | 750 | 10 | 1.35% |
| Dec 31, 2014 | 740 | 34 | 4.82% |
| Dec 31, 2013 | 706 | 83 | 13.32% |
| Dec 31, 2012 | 623 | 80 | 14.73% |
| Dec 31, 2011 | 543 | 23 | 4.42% |
| Dec 31, 2010 | 520 | 110 | 26.83% |
| Dec 31, 2009 | 410 | 50 | 13.89% |
| Dec 31, 2008 | 360 | 40 | 12.50% |
| Dec 31, 2007 | 320 | 35 | 12.28% |
| Dec 31, 2006 | 285 | 75 | 35.71% |
| Dec 31, 2005 | 210 | 40 | 23.53% |
| Dec 31, 2004 | 170 | 10 | 6.25% |
| Dec 31, 2003 | 160 | 10 | 6.67% |
| Dec 31, 2002 | 150 | 22 | 17.19% |
| Dec 31, 2001 | 128 | 18 | 16.36% |
| Dec 31, 2000 | 110 | 47 | 74.60% |
| Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 32,000 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,561 |
| Zoetis | 13,800 |
| Elanco Animal Health | 9,450 |
| Amneal Pharmaceuticals | 8,300 |
UTHR News
- 19 hours ago - United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026 - Business Wire
- 16 days ago - United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure - Business Wire
- 20 days ago - United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - Business Wire
- 4 weeks ago - United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - 6 stocks and ETFs that these unsung market heroes see outperforming in 2026 - Market Watch
- 5 weeks ago - United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Flurry of Bullish Inflows Sends United Therapeutics Higher - FXEmpire
- 3 months ago - United Therapeutics Corporation (UTHR) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha